Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process

Journal of Inherited Metabolic Disease

Volumn 32, Issue 4, 2009, Pages 551-559

  Hulkova H ^a   Ledvinova J ^a   Poupetova H ^a   Kohout, A ^b   Malinova V ^b   Elleder, M ^a  

^a General Teaching Hospital and 1st Medical Faculty of Charles University   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; D DIMER; IMIGLUCERASE; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADIPOCYTE; ADULT; ALTITUDE DISEASE; ANAMNESIS; ARTHRALGIA; ARTICLE; AUTOPSY; BILE DUCT CARCINOMA; BRAIN HEMORRHAGE; BRAIN REGION; CASE REPORT; CELL; CELL INFILTRATION; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPATHOLOGY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; ENZYME REPLACEMENT; FEMALE; GAUCHER CELL; GAUCHER DISEASE; GRAY MATTER; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAHEPATIC CHOLESTASIS; JOINT SWELLING; LEPTOMENINX; LIVER CARCINOMA; LUNG EDEMA; MACROPHAGE; MULTIPLE ORGAN FAILURE; SEPSIS; SPLENOMEGALY; WHITE MATTER;

AUTOPSY; BIOLOGICAL TRANSPORT, ACTIVE; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 69449103951     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1178-9     Document Type: Article

References (26)

1. Blanchette-Mackie EJ, Briggs T, Chernick, SS et al. (1986) Lipolysis of serum-activated triacylglycerol at the surface of J774.1 macrophages. A biochemical-electron-microscopic study. Cell Tissue Res 244 (1):95-105. doi: 10.1007/BF00218386
2. Brady RO, King FM (1973) Gaucher's Diseasedisease. In: Hers HG, Van Hoof F, eds. Lysosomes and storage Storage diseasesDiseases. New York: Academic Press, 381-394.
3. Brady RO, Pentchev PG, Gal AE, et al. (1974) Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's Gaucher's disease. N Engl J Med 291 (19):989-993.
4. Breiden-Langen CM, Buchsel R, Brambs HJ, et al. (1991) Coincidence of Gaucher disease with primary hepatocellular carcinoma]. Leber Magen Darm 21 (3):126, 129-130.
5. Conradi NG, Kalimo H, Sourander P (1988) Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 75 (4):385-390. doi: 10.1007/BF00687792
6. Cox TM (2005) Biomarkers in lysosomal storage diseases: A review. Acta Daediatr Suppl 94 (447):39-42: discussion 37-38. doi: 10.1080/ 08035320510028085
7. Daniels LB, Glew RH, Radin NS, et al. (1980) A revised fluorometric assay for Gaucher's Gaucher's disease using conduritol-beta-epoxide with liver as the source of Betabeta-glucosidase. Clin Chim Acta 106 (2):155-163. doi: 10.1016/0009-8981(80)90168-0
8. Daniels LB, Coyle PJ, Glew RH, et al. (1982) Brain glucocerebrosidase in Gaucher's Gaucher's disease. Arch Neurol 39 (9):550-556
9. de Fost M, Vom Dahl S, Weverling GJ, et al. (2006) Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 36 (1):53-58. doi: 10.1016/j.bcmd.2005.08.004
10. Deegan PB, Moran MT, McFarlane I et al. (2005) Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis 35 (2):259-267. doi: 10.1016/j.bcmd.2005.05.005
11. Desnick RJ, Gatt S, Grabowski GA (1982) Progress in Clinical and Biological Research. Gaucher Disease: A Century of Delineation and Research. New York: Alan R. Liss
12. Elleder M (2006) Glucosylceramide transfer from lysosomes-the missing link in molecular pathology of glucosylceramidase deficiency: A hypothesis based on existing data. J Inherit Metab Dis 29 (6):707-715. doi: 10.1007/s10545-006-0411-z
13. Erjavec Z, Hollak CE, de Vries EG (1999) Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy. Ann Oncol 10 (2):243. doi: 10.1023/A:1008306414822
14. Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2863-2914
15. Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher's Gaucher's disease. Lancet 372 (9645):1263-1271. doi: 10.1016/ S0140-6736(08)61522-6
16. Hartree EF (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem 48 (2):422-427. doi: 10.1016/0003-2697(72)90094-2
17. Hill SC, Reinig JW, Barranger JA, et al. (1986) Gaucher disease: sonographic appearance of the spleen. Radiology 160 (3):631-634.
18. Keslova-Veselikova J, Hulkova H, Dobrovolny R, et al. (2008) Replacement of alpha-galactosidase A in Fabry disease: Effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch 452 (6):651-665. doi: 10.1007/s00428-008-0586-9
19. Landgren O, Turesson I, Gridley G, et al. (2007) Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease. Arch Intern Med 167 (11):1189-1194. doi: 10.1001/archinte.167.11.1189
20. Leinekugel P, Michel S, Conzelmann E et al. (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88 (5):513-523. doi: 10.1007/BF00219337
21. Markwell MA, Haas SM, Tolbert NE, et al. (1981) Protein determination in membrane and lipoprotein samples: Manual and automated procedures. Methods Enzymol 72: 296-303.
22. Neudorfer O, Hadas-Halpern I, Elstein D, et al. (1997) Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients. Am J Hematol 55 (1):28-34. doi: 10.1002/ (SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5
23. Soffer D, Yamanaka T, Wenger DA, et al. (1980) Central nervous system involvement in adult-onset Gaucher's Gaucher's disease. Acta Neuropathol 49 (1):1-6. doi: 10.1007/BF00692212
24. Wenger DA, Williams C (1991) Screening for Lysosomal lysosomal Disordersdisorders. In: Hommes FA, eds. Techniques in Diagnostic Human Biochemical Genetics. New York: Willey-Liss, 587-617.
25. Xu R, Mistry P, McKenna G, et al. (2005) Hepatocellular carcinoma in type 1 Gaucher disease: A case report with review of the literature. Semin Liver Dis 25 (2):226-229. doi: 10.1055/s-2005-871201
26. Zimran A, Liphshitz I, Barchana M, et al. (2005) Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic. Blood Cells Mol Dis 34 (3):197-200. doi: 10.1016/ j.bcmd.2005.03.004